Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD9829 / AstraZeneca
阿斯利康 B7-H4 ADC 国内临床即将启动！中国研发提速中_药物_Enhertu_研究
Discovery of AZD9833, a potent and orally bioavailable selective ...
阿斯利康靶向CD123的ADC AZD9829在中国获批临床，治疗血液肿瘤
阿斯利康：靶向CD123 ADC产品国内申报临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
阿斯利康靶向CD123的ADC AZD9829在中国申报临床，治疗血液肿瘤
First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising ...
阿斯利康 9 款 1 类新药在中国获批临床，多款国内进度位于第一梯队
Lixarkitug (AZD9829 antibody) | Anti IL-3Ra/CD123 Antibody | MedChemExpress
In Vivo Anticancer Activity of AZD3965: A Systematic Review
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus ...
Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the ...
AZD9291 binding mode and structure. A, Structural model showing the ...
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in ...
AACR2023| ADC药物及可用临床前动物模型 - 知乎
What Type Of Mutation Causes Colorectal Cancer
Dual Src-Abl kinase inhibitors AZD0530 and dasatinib inhibit DV2 ...
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC ...
Compilation of 13 FDA-Approved ADC (Antibody-Drug Conjugate) Medications
阿斯利康自研ADC崛起_腾讯新闻
Pivekimab sunirine (IMGN 632) is a CD123-targeting ADC for ...
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer ...
密西根大学张阳实验室郑伟博士在CASP15蛋白质结构预测大赛中斩获多项冠军_casp15冠军-CSDN博客
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
AD9869 Datasheet and Product Info | Analog Devices
Full article: Azacitidine and decitabine have different mechanisms of ...
Azacitidine pre-treatment enhances anti-CD123 CAR T cell-mediated AML ...
Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia ...
(PDF) Payload diversification: a key step in the development of ...
Azacitidine treatment leads to enhanced CD123 expression on AML ...
Full article: A review of antibody-based immunotherapy clinical trials ...
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics ...
Synergistic interaction between AZD1208 and AZD2014 in AML cells. A ...
AZD7762 inhibits MerTK activity in lung cancer cell lines. (A) H1299 ...
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody ...
Full article: Comprehensive Performance Evaluation of Ligand-Binding ...
Development of Highly Optimized Antibody–Drug Conjugates against CD33 ...
혈액암 개발 속도 붙이는 AZ…일주일 새 3건 임상 1/2상 IND 승인
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain ...
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive ...
(a and b) imprint cytology and (c) histopathology of Serous ...
Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus ...
Molecular characterization and cytotoxic effects of AZD5363, AZD8542 ...
AZD5991 induces intrinsic apoptosis in AML cells. (A) MOLM-13 and THP-1 ...
GitHub - marunemitsu/QTFluent: QT Fluent: A Windows11 and Office style ...
Dual Kinase Targeting in Leukemia
Antibody-drug Conjugate Information | ADCdb
Anti-CD123 CAR CIK cells have a better safety profile against normal CB ...
Signaling and cell cycle effects of AZD8055 treatment with AZD6244. A ...
CD123 is an excellent target in primary AML in vivo. (A) Primary AML ...
Figure S2. Primary AML cells from 6 patients were treated with AZD1208 ...
Discovery of novel hypoxia-activated, nitroimidazole constructed multi ...
AZD8055 | CAS 1009298-09-2 | AbMole BioScience | AZD8055 Price
Straight to the Point—The Novel Strategies to Cure Pediatric AML
阿斯利康「CD19/CD3双抗」在华获批临床 - 知乎
Antibody–Drug Conjugates: Perspectives and Characterization ...
Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1 ...
AZD5991 靶向药 - 基因医生
A CD123-targeting antibody-drug conjugate, IMGN632, designed to ...
Impact of Drug Conjugation and Loading on Target Antigen Binding and ...
泰德制药AT2R拮抗剂TRD205获批临床，针对神经病理性疼痛
Pharmaceutics | Free Full-Text | Effects of Lactate Transport ...
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 ...
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and ...
AZD0233
有望成为首款！阿尔茨海默病口服TAU蛋白聚集抑制剂HMTM 3期临床试验结果积极
AZD8055 inhibits protein translation in AML cells. (a) 7mGTP affinity ...
c-Myc inhibition synergizes with AZD5991 in inducing apoptosis in AML ...
Model Informed Drug Discovery and Development (MID3): genesis of ...
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial ...
Antibody–Drug Conjugates: The Last Decade
Tumor-Targeted Antibodies | SpringerLink
Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable ...
In vivo efficacy of AZD5582-based combination treatments a, Frequencies ...
SIRPα-αCD123 fusion antibodies stimulate phagocytosis of AML patient ...
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic ...
AZD8529 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Chinese Medical Journal
Preemptive optimization of a clinical antibody for broad neutralization ...
AZD7762 | 购买Chk 抑制剂 - Selleck
Frontiers | Reversal of Cancer Multidrug Resistance (MDR) Mediated by ...
全球首发！勃林格殷格翰IL-36R单抗佩索利单抗皮下注射制剂在华获批上市
Figure 1 from AZD4573 Is a Highly Selective CDK9 Inhibitor That ...
slide40
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor ...
AZ20 synergizes with cytarabine (ara-C) to induce apoptosis and ...
Multiomics of azacitidine-treated AML cells reveals variable and ...
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell ...
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression ...
Full article: Development and preclinical characterization of AMG 329 ...
Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like ...
Multiomics of Azacitidine-Treated AML Cells Reveals Variable And - DocsLib
Innovation in Chemistry, Manufacturing, and Controls—A Regulatory ...
-2.jpg)
